"Nicotine: Potential therapies and possible pitfalls"
“尼古丁:潜在的疗法和可能的陷阱”
基本信息
- 批准号:6808063
- 负责人:
- 金额:$ 2.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-07 至 2004-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The purpose of this proposal is to request funds to support a one day satellite symposium entitled "Nicotine: Potential therapies and possible pitfalls" to the 2004 International Behavioral Neuroscience Society (IBNS) Conference in Key West, FL. The dates for this meeting are from June 16th to June 20th, 2004. The recent and exciting developments in nicotine research represent a specific need for this symposium. Although there have been several other symposia focused on nicotine over the past few years, most of these have focused on a specific research area, such as nicotine as an addictive drug or on its effects relative to a specific behavioral disorder or neurodegenerative disease. The proposed symposium is designed to convene experts from across the diverse areas of nicotine research to identify nicotine's therapeutic potential, the possible pitfalls of utilizing nicotine as a therapeutic agent, and potential mechanisms of action. A primary goal for this meeting is to encourage discussion amongst scientists from diverse research backgrounds and with wide-ranging interests that can reveal commonalities of approach regarding nicotine as a potential therapy, as well as the positive and negative consequences of nicotine administration in a variety of behavioral, cognitive and neurological research models.
However, because nicotine is a psychostimulant, the psychoactive ingredient in tobacco and believed to be the primary ingredient responsible for nicotine addiction, there are obvious potential pitfalls to using nicotine as a therapeutic agent. On the other hand, nicotine and agonists to the acetylcholinergic nicotinic receptor have been shown to eliminate anxiety when given at low doses, enhance cognition, and to significantly reduce, or even eliminate cognitive deficits produced by brain injury and sensory deficits in schizophrenics. Nicotine also increases neurotrophic factor expression and this effect of the drug may have an important role in neuroprotection in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Therefore, several topics across this field will be covered, including underlying mechanisms of nicotine addiction, the role of the nicotinic receptor in behavior and neuroprotection, nicotine's potential therapeutic effects in Alzheimer's and Parkinson's disease, nicotine's role in anxiety, and it's effects on behavior in schizophrenia and brain trauma in animal models as well as humans.
The symposium is also designed to bring together a group of scientists at all career levels including graduate students, post-doctoral fellows, assistant, associate, and full professors. In doing this we hope to provide a stimulating environment for the more senior researchers and a nurturing environment for the more junior participants. Additionally, the scientific background of these scientists is also very diverse. The research disciplines of the invitees to the symposium range from molecular neuroscience to behavioral neuroscience and neurology that also work with a variety of species, ranging from rodent to primate to human. Although speakers and session leaders will provide an introduction suited for the less acquainted attendee, presentations will be geared to late-breaking, novel and often unpublished findings to bring as many people to the forefront of the field as possible. In addition to the organizers, eleven scientists have accepted invitations to this symposium, and each will present their latest research in a 30-minute talk. Additionally, we plan a final roundtable discussion with all speakers to discuss the commonalities of the positive effects, underlying mechanisms, and adverse effects of nicotine as a potential therapy.
描述(由申请人提供):
该提案的目的是请求资金支持在佛罗里达州基韦斯特举行的 2004 年国际行为神经科学学会 (IBNS) 会议上举办为期一天的题为“尼古丁:潜在疗法和可能的陷阱”的卫星研讨会。本次会议的日期为2004年6月16日至6月20日。尼古丁研究的最新令人兴奋的发展代表了本次研讨会的特殊需要。尽管过去几年还有其他几个关注尼古丁的研讨会,但其中大多数都集中在特定的研究领域,例如尼古丁作为成瘾药物或其对特定行为障碍或神经退行性疾病的影响。拟议的研讨会旨在召集来自尼古丁研究不同领域的专家,以确定尼古丁的治疗潜力、利用尼古丁作为治疗剂的可能陷阱以及潜在的作用机制。本次会议的主要目标是鼓励来自不同研究背景和广泛兴趣的科学家之间进行讨论,这些讨论可以揭示尼古丁作为潜在疗法的方法的共性,以及尼古丁在各种情况下施用的积极和消极后果行为、认知和神经学研究模型。
然而,由于尼古丁是一种精神兴奋剂,是烟草中的精神活性成分,并且被认为是导致尼古丁成瘾的主要成分,因此使用尼古丁作为治疗剂存在明显的潜在陷阱。另一方面,低剂量的尼古丁和乙酰胆碱能烟碱受体激动剂已被证明可以消除焦虑,增强认知,并显着减少甚至消除精神分裂症患者因脑损伤和感觉缺陷而产生的认知缺陷。尼古丁还可以增加神经营养因子的表达,该药物的这种作用可能在阿尔茨海默病和帕金森病等神经退行性疾病的神经保护中发挥重要作用。因此,该领域的几个主题将被涵盖,包括尼古丁成瘾的潜在机制、烟碱受体在行为和神经保护中的作用、尼古丁对阿尔茨海默病和帕金森病的潜在治疗作用、尼古丁在焦虑中的作用以及它对行为的影响。动物模型和人类的精神分裂症和脑损伤。
该研讨会还旨在聚集各个职业级别的科学家,包括研究生、博士后研究员、助理、副教授和正教授。在此过程中,我们希望为更高级的研究人员提供一个激励的环境,为更初级的参与者提供一个培育的环境。此外,这些科学家的科学背景也非常多样化。研讨会受邀者的研究学科范围从分子神经科学到行为神经科学和神经学,这些学科还涉及从啮齿动物到灵长类动物再到人类等多种物种。尽管演讲者和会议主持人将为不太熟悉的与会者提供适合的介绍,但演示文稿将针对最新的、新颖的且通常未发表的发现,以将尽可能多的人带到该领域的最前沿。除主办方外,已有11位科学家接受了本次研讨会的邀请,每位科学家都将在30分钟的演讲中展示他们的最新研究成果。此外,我们计划与所有发言者进行最后的圆桌讨论,讨论尼古丁作为潜在疗法的积极作用、潜在机制和不良反应的共性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUSSELL WAYNE BROWN其他文献
RUSSELL WAYNE BROWN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUSSELL WAYNE BROWN', 18)}}的其他基金
A first-in-class orally bioavailable small molecule dual inhibitor targeting NLRP3 and the dopamine transporter to treat AD
首创的口服生物可利用小分子双重抑制剂,靶向 NLRP3 和多巴胺转运蛋白,用于治疗 AD
- 批准号:
10325722 - 财政年份:2021
- 资助金额:
$ 2.4万 - 项目类别:
Nicotine and the roles of nicotinic receptors in a rodent model of schizophrenia
尼古丁和烟碱受体在啮齿动物精神分裂症模型中的作用
- 批准号:
8574551 - 财政年份:2013
- 资助金额:
$ 2.4万 - 项目类别:
Nicotine and the roles of nicotinic receptors in a rodent model of schizophrenia
尼古丁和烟碱受体在啮齿动物精神分裂症模型中的作用
- 批准号:
8848228 - 财政年份:2013
- 资助金额:
$ 2.4万 - 项目类别:
Nicotine and the roles of nicotinic receptors in a rodent model of schizophrenia
尼古丁和烟碱受体在啮齿动物精神分裂症模型中的作用
- 批准号:
9011776 - 财政年份:2013
- 资助金额:
$ 2.4万 - 项目类别:
Amphetamine sensitization in a model of schizophrenia
精神分裂症模型中的安非他明致敏
- 批准号:
8082092 - 财政年份:2006
- 资助金额:
$ 2.4万 - 项目类别:
Amphetamine sensitization in a model of schizophrenia
精神分裂症模型中的安非他明致敏
- 批准号:
7854121 - 财政年份:2006
- 资助金额:
$ 2.4万 - 项目类别:
Amphetamine sensitization in a model of schizophrenia
精神分裂症模型中的安非他明致敏
- 批准号:
7127485 - 财政年份:2006
- 资助金额:
$ 2.4万 - 项目类别:
相似国自然基金
2012年全国青年摩擦学学术会议暨第六届生物摩擦学与内植物工程学术研讨会
- 批准号:51245004
- 批准年份:2012
- 资助金额:5.0 万元
- 项目类别:专项基金项目
中国神经科学学会青年学者研讨会暨第八届全国学术会议
- 批准号:30949006
- 批准年份:2009
- 资助金额:3.0 万元
- 项目类别:专项基金项目
相似海外基金
The Rodin Remediation Academy Conference: Neural Basis of Skill Acquisition, Rea
罗丹矫正学院会议:技能习得的神经基础,Rea
- 批准号:
7209701 - 财政年份:2005
- 资助金额:
$ 2.4万 - 项目类别:
Neural Circuits and Plasticity Gordon Conference
神经回路和可塑性戈登会议
- 批准号:
6941036 - 财政年份:2005
- 资助金额:
$ 2.4万 - 项目类别:
The Rodin Remediation Academy Conference: Neural Basis of Skill Acquisition, Rea
罗丹矫正学院会议:技能习得的神经基础,Rea
- 批准号:
7001168 - 财政年份:2005
- 资助金额:
$ 2.4万 - 项目类别: